Jeffrey Bluestone, Director at GILEAD SCIENCES, INC. (GILD), sold 5,000 shares at $143.75 ($725K) on 2026-08-20, disclosed to the SEC on 2026-08-21.
Scheduled sale ($725k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $143.75 | 1,165 | $167K | 23.1% |
| 2 | $144.92 | 1,816 | $263K | 36.3% |
| 3 | $145.73 | 1,658 | $242K | 33.3% |
| 4 | $146.26 | 335 | $49K | 6.8% |
| 5 | $146.36 | 26 | $4K | 0.5% |
| Total | $145.02 avg | 5,000 |
| $725K |
| 100% |
| Filing → |
| GILD | SELL | 2025-07-15 | $549K | — | Filing → |
| GILD | SELL | 2024-11-27 | $1.2M | — | Filing → |
| PRVB | SELL | 2019-06-17 | $87K | — | Filing → |